Anemia drugs

Marketing

FibroGen, Astellas find roxadustat support from NICE

NICE noted that oral Evrenzo could serve as an alternative to existing erythropoiesis stimulating agents, which are injectables.
Angus Liu Jun 9, 2022 10:32am

Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia

May 20, 2022 9:15am

Roxadustat's safety passed muster in a pooled analysis

May 19, 2022 2:01am

Otsuka drops Akebia in oral anemia drug pact

May 16, 2022 9:23am

AZ, FibroGen clash on roxa's US path forward in CKD anemia

May 10, 2022 8:05am

Could the third time be the charm for an oral anemia med at FDA?

Apr 19, 2022 10:27am